MedTrace Logo

The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)

NCT04062942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-07-26

No results posted yet for this study

Summary

The primary objective is to determine the validity of the Six-Minute-Walking Test (6WT) and Timed-Up and Go (TUG) test to measure objective functional impairment (OFI) in patients undergoing either interlaminar epidural steroid injection (ESI) or transforaminal epidural steroid injections (TFESI) for lumbar degenerative disc disease (DDD)

Conditions

  • Lumbar Disc Disease
  • Lumbar Spine Degeneration
  • Lumbar Spinal Stenosis

Sponsors & Collaborators

  • Prof. Dr. Astrid Weyerbrock, Klinik für Neurochirurgie, Kantonsspital St. Gallen

    collaborator UNKNOWN

  • PD Dr. med. Martin Stienen, Klinik für Neurochirurgie, Universitätsspital Zürich

    collaborator UNKNOWN

  • PD Dr. med. David Bellut, Klinik für Neurochirurgie, Universitätsspital Zürich

    collaborator UNKNOWN

  • med. pract. Markéta Sosnová, Klinik für Neurochirurgie, Kantonsspital St. Gallen

    collaborator UNKNOWN

  • med. pract. Michal Ziga, Klinik für Neurochirurgie, Kantonsspital St. Gallen

    collaborator UNKNOWN

  • med. pract.Valentin Steinsiepe, Klinik für Neurochirurgie, Kantonsspital St. Gallen

    collaborator UNKNOWN

  • Dr. med. Anna Zeitlberger, Klinik für Neurochirurgie, Kantonsspital St. Gallen

    collaborator UNKNOWN

  • PD Dr. med. Oliver Gautschi, Neuro- und Wirbelsäulen Zentrum Zentralschweiz, Luzern

    collaborator UNKNOWN

  • Cantonal Hospital of St. Gallen

    lead OTHER

Principal Investigators

  • Nicolai Maldaner, MD · Kantonsspital St. Gallen / Department of Neurosurgery

  • Martin Stienen, MD · Universitätsspital Zürich / Department of Neurosurgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-15
Primary Completion
2021-12-20
Completion
2021-12-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04062942 on ClinicalTrials.gov